SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'RBF'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BX4_A_ADNA355_1 (PROTEIN (ADENOSINEKINASE)) |
4iil | MEMBRANE LIPOPROTEINTPN38(B) (Treponemapallidum) | 5 / 12 | VAL A 26GLN A 121ILE A 164GLY A 154ILE A 213 | RBF A 401 (-3.9A)RBF A 401 (-3.3A)RBF A 401 ( 4.7A)NoneRBF A 401 (-3.7A) | 0.89A | 1bx4A-4iilA:4.9 | 1bx4A-4iilA:21.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1D4F_B_ADNB602_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 4 / 5 | THR A 71THR A 67THR A 50HIS A 44 | NoneRBF A 98 (-3.1A)NoneNone | 1.34A | 1d4fB-1hzeA:undetectable | 1d4fB-1hzeA:12.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FM6_D_BRLD503_2 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 4 / 4 | ILE A 63LEU A 83VAL A 81ILE A 12 | RBF A 187 ( 4.6A)NoneNoneNone | 0.89A | 1fm6D-3ddyA:undetectable | 1fm6D-3ddyA:19.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FXV_B_PNNB1001_0 (PENICILLIN ACYLASE) |
5w4z | RIBOFLAVIN LYASE (Herbiconiux) | 4 / 7 | PHE A 248SER A 232SER A 22PHE A 14 | 9WY A 501 (-3.4A)9WY A 501 (-3.6A)RBF A 502 (-3.8A)RBF A 502 (-3.6A) | 1.14A | 1fxvA-5w4zA:undetectable1fxvB-5w4zA:undetectable | 1fxvA-5w4zA:undetectable1fxvB-5w4zA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I18_A_RBFA98_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 7 / 10 | CYH A 48LEU A 49ASP A 62LEU A 63THR A 67ILE A 70THR A 71 | RBF A 98 (-3.3A)RBF A 98 (-3.8A)RBF A 98 (-2.7A)RBF A 98 (-4.1A)RBF A 98 (-3.1A)RBF A 98 ( 4.1A)None | 0.23A | 1i18A-1hzeA:20.41i18B-1hzeA:20.2 | 1i18A-1hzeA:100.001i18B-1hzeA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I18_B_RBFB99_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 7 / 10 | CYH A 48LEU A 49ASP A 62LEU A 63THR A 67ILE A 70THR A 71 | RBF A 98 (-3.3A)RBF A 98 (-3.8A)RBF A 98 (-2.7A)RBF A 98 (-4.1A)RBF A 98 (-3.1A)RBF A 98 ( 4.1A)None | 0.23A | 1i18A-1hzeA:20.41i18B-1hzeA:20.2 | 1i18A-1hzeA:100.001i18B-1hzeA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N13_B_AG2B7011_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAIN) |
4e0f | RIBOFLAVIN SYNTHASESUBUNIT ALPHA (Brucellaabortus) | 4 / 5 | GLU A 70ARG A 192LEU A 74ASP A 108 | NoneNoneRBF A 301 ( 4.8A)None | 1.28A | 1n13B-4e0fA:undetectable1n13C-4e0fA:undetectable | 1n13B-4e0fA:23.761n13C-4e0fA:17.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PKV_A_RBFA100_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 5 / 11 | CYH A 47CYH A 48LEU A 49THR A 50THR A 71 | NoneRBF A 98 (-3.3A)RBF A 98 (-3.8A)NoneNone | 1.24A | 1pkvA-1hzeA:13.91pkvB-1hzeA:13.7 | 1pkvA-1hzeA:100.001pkvB-1hzeA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PKV_A_RBFA100_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 5 / 11 | CYH A 48LEU A 49THR A 50ILE A 70THR A 71 | RBF A 98 (-3.3A)RBF A 98 (-3.8A)NoneRBF A 98 ( 4.1A)None | 1.14A | 1pkvA-1hzeA:13.91pkvB-1hzeA:13.7 | 1pkvA-1hzeA:100.001pkvB-1hzeA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PKV_A_RBFA100_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 5 / 11 | SER A 41CYH A 47LEU A 49THR A 50THR A 71 | NoneNoneRBF A 98 (-3.8A)NoneNone | 1.04A | 1pkvA-1hzeA:13.91pkvB-1hzeA:13.7 | 1pkvA-1hzeA:100.001pkvB-1hzeA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PKV_A_RBFA100_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
4e0f | RIBOFLAVIN SYNTHASESUBUNIT ALPHA (Brucellaabortus) | 6 / 11 | SER A 40CYH A 47LEU A 48THR A 49THR A 75VAL A 107 | RBF A 301 (-3.3A)RBF A 301 (-3.4A)RBF A 301 (-4.4A)RBF A 301 (-3.9A)NoneRBF A 301 (-3.9A) | 0.30A | 1pkvA-4e0fA:14.91pkvB-4e0fA:15.1 | 1pkvA-4e0fA:24.291pkvB-4e0fA:24.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PKV_B_RBFB101_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 5 / 11 | CYH A 47CYH A 48LEU A 49THR A 50THR A 71 | NoneRBF A 98 (-3.3A)RBF A 98 (-3.8A)NoneNone | 1.19A | 1pkvA-1hzeA:13.91pkvB-1hzeA:13.7 | 1pkvA-1hzeA:100.001pkvB-1hzeA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PKV_B_RBFB101_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 5 / 11 | CYH A 48LEU A 49THR A 50ILE A 70THR A 71 | RBF A 98 (-3.3A)RBF A 98 (-3.8A)NoneRBF A 98 ( 4.1A)None | 1.11A | 1pkvA-1hzeA:13.91pkvB-1hzeA:13.7 | 1pkvA-1hzeA:100.001pkvB-1hzeA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PKV_B_RBFB101_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 5 / 11 | SER A 41CYH A 47LEU A 49THR A 50THR A 71 | NoneNoneRBF A 98 (-3.8A)NoneNone | 1.03A | 1pkvA-1hzeA:13.91pkvB-1hzeA:13.7 | 1pkvA-1hzeA:100.001pkvB-1hzeA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PKV_B_RBFB101_1 (RIBOFLAVIN SYNTHASEALPHA CHAIN) |
4e0f | RIBOFLAVIN SYNTHASESUBUNIT ALPHA (Brucellaabortus) | 6 / 11 | VAL A 107SER A 40CYH A 47LEU A 48THR A 49THR A 75 | RBF A 301 (-3.9A)RBF A 301 (-3.3A)RBF A 301 (-3.4A)RBF A 301 (-4.4A)RBF A 301 (-3.9A)None | 0.28A | 1pkvA-4e0fA:14.91pkvB-4e0fA:15.1 | 1pkvA-4e0fA:24.291pkvB-4e0fA:24.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UHO_A_VDNA1000_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 5 / 10 | ALA A 115PHE A 118LEU A 122MET A 79GLY A 76 | NoneNoneNoneRBF A 201 (-3.5A)RBF A 201 (-2.9A) | 1.50A | 1uhoA-5kbwA:undetectable | 1uhoA-5kbwA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XP0_A_VDNA201_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
4e0f | RIBOFLAVIN SYNTHASESUBUNIT ALPHA (Brucellaabortus) | 6 / 10 | LEU A 88ALA A 42ILE A 41ALA A 67LEU A 23PHE A 63 | NoneNoneNoneRBF A 301 (-4.1A)NoneNone | 1.48A | 1xp0A-4e0fA:undetectable | 1xp0A-4e0fA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G70_A_SAMA2001_0 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
4p6v | NA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT ANA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT BNA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT E (Vibriocholerae;Vibriocholerae;Vibriocholerae) | 5 / 12 | TYR E 166ASP B 397VAL B 401HIS B 398ALA A 410 | NoneNoneNoneRBF E 201 ( 4.9A)None | 1.23A | 2g70A-4p6vE:undetectable | 2g70A-4p6vE:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G70_B_SAMB2002_0 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
4p6v | NA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT ANA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT BNA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT E (Vibriocholerae;Vibriocholerae;Vibriocholerae) | 5 / 12 | TYR E 166ASP B 397VAL B 401HIS B 398ALA A 410 | NoneNoneNoneRBF E 201 ( 4.9A)None | 1.29A | 2g70B-4p6vE:undetectable | 2g70B-4p6vE:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QEO_A_LNRA200_1 (D7R4 PROTEIN) |
4p6v | NA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT ANA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT BNA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT E (Vibriocholerae) | 5 / 12 | GLU B 402TYR E 166HIS B 398VAL E 35ASP A 401 | RBF E 201 (-4.8A)NoneRBF E 201 ( 4.9A)NoneNone | 1.48A | 2qeoA-4p6vB:undetectable | 2qeoA-4p6vB:13.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QHF_A_ACTA503_0 (CHORISMATE SYNTHASE) |
5w4z | RIBOFLAVIN LYASE (Herbiconiux) | 4 / 5 | GLN A 343THR A 342ARG A 346ALA A 345 | RBF A 502 (-4.1A)9WY A 501 (-3.7A)NoneNone | 1.28A | 2qhfA-5w4zA:undetectable | 2qhfA-5w4zA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2TSR_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
1hze | RIBOFLAVIN SYNTHASEALPHA CHAIN (Escherichiacoli) | 4 / 8 | ILE A 70ASP A 75LEU A 73GLY A 74 | RBF A 98 ( 4.1A)NoneNoneNone | 0.96A | 2tsrB-1hzeA:undetectable | 2tsrB-1hzeA:15.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A35_A_RBFA191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 6 / 12 | CYH A 47ASP A 64GLN A 65ALA A 66ASN A 101ILE A 102 | RBF A 187 (-3.3A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)RBF A 187 (-3.7A)RBF A 187 (-4.4A) | 0.87A | 3a35A-3ddyA:29.7 | 3a35A-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A35_A_RBFA191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 10 / 12 | VAL A 41CYH A 47SER A 48THR A 50ASP A 64GLN A 65ALA A 66THR A 69THR A 70ILE A 102 | RBF A 187 ( 4.5A)RBF A 187 (-3.3A)RBF A 187 (-4.3A)RBF A 187 (-4.4A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)RBF A 187 (-3.2A)NoneRBF A 187 (-4.4A) | 0.36A | 3a35A-3ddyA:29.7 | 3a35A-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A35_B_RBFB191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 6 / 12 | CYH A 47ASP A 64GLN A 65ALA A 66ASN A 101ILE A 102 | RBF A 187 (-3.3A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)RBF A 187 (-3.7A)RBF A 187 (-4.4A) | 0.79A | 3a35B-3ddyA:30.7 | 3a35B-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A35_B_RBFB191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 10 / 12 | VAL A 41CYH A 47SER A 48THR A 50ASP A 64GLN A 65ALA A 66THR A 69THR A 70ILE A 102 | RBF A 187 ( 4.5A)RBF A 187 (-3.3A)RBF A 187 (-4.3A)RBF A 187 (-4.4A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)RBF A 187 (-3.2A)NoneRBF A 187 (-4.4A) | 0.33A | 3a35B-3ddyA:30.7 | 3a35B-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A3B_A_RBFA191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 7 / 12 | CYH A 47ASP A 64GLN A 65ALA A 66THR A 70ASN A 101ILE A 102 | RBF A 187 (-3.3A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)NoneRBF A 187 (-3.7A)RBF A 187 (-4.4A) | 0.80A | 3a3bA-3ddyA:29.3 | 3a3bA-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A3B_A_RBFA191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 10 / 12 | VAL A 41CYH A 47SER A 48THR A 50ASP A 64GLN A 65ALA A 66THR A 69THR A 70ILE A 102 | RBF A 187 ( 4.5A)RBF A 187 (-3.3A)RBF A 187 (-4.3A)RBF A 187 (-4.4A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)RBF A 187 (-3.2A)NoneRBF A 187 (-4.4A) | 0.37A | 3a3bA-3ddyA:29.3 | 3a3bA-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A3B_A_RBFA191_1 (LUMAZINE PROTEIN) |
3ddy | LUMAZINE PROTEIN (Photobacteriumleiognathi) | 8 / 12 | VAL A 41SER A 48THR A 50ASP A 64GLN A 65ALA A 66THR A 70ILE A 102 | RBF A 187 ( 4.5A)RBF A 187 (-4.3A)RBF A 187 (-4.4A)RBF A 187 (-4.4A)RBF A 187 (-3.7A)RBF A 187 (-3.1A)NoneRBF A 187 (-4.4A) | 1.48A | 3a3bA-3ddyA:29.3 | 3a3bA-3ddyA:55.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F8F_A_DM1A127_1 (TRANSCRIPTIONALREGULATOR, PADR-LIKEFAMILY) |
4zzd | TRANSCRIPTIONALREGULATOR, PADR-LIKEFAMILY (Lactococcuslactis) | 6 / 10 | MET A 8ALA A 11VAL A 15ALA A 92PHE A 93TRP A 96 | NoneRBF A 201 (-3.6A)RBF A 201 (-4.7A)RBF A 201 ( 4.5A)NoneRBF A 201 (-3.2A) | 0.70A | 3f8fA-4zzdA:16.43f8fB-4zzdA:16.3 | 3f8fA-4zzdA:100.003f8fB-4zzdA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KKZ_B_SAMB302_0 (UNCHARACTERIZEDPROTEIN Q5LES9) |
5w4z | RIBOFLAVIN LYASE (Herbiconiux) | 5 / 12 | GLY A 244GLY A 231GLY A 236SER A 340ALA A 230 | None9WY A 501 (-3.3A)9WY A 501 ( 4.5A)RBF A 502 (-3.1A)9WY A 501 (-3.4A) | 1.06A | 3kkzB-5w4zA:undetectable | 3kkzB-5w4zA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P5N_A_RBFA190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 6 / 12 | LEU A 34ASP A 73GLY A 76ASN A 123ASN A 149LYS A 152 | RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-2.1A)RBF A 201 (-1.8A)RBF A 201 (-3.7A) | 0.87A | 3p5nA-5kbwA:24.2 | 3p5nA-5kbwA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P5N_A_RBFA190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 6 / 12 | LEU A 34ASP A 73GLY A 76LEU A 83ASN A 149LYS A 152 | RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-4.5A)RBF A 201 (-1.8A)RBF A 201 (-3.7A) | 1.38A | 3p5nA-5kbwA:24.2 | 3p5nA-5kbwA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P5N_B_RBFB190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 6 / 12 | LEU A 34ASP A 73GLY A 76ASN A 123ASN A 149LYS A 152 | RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-2.1A)RBF A 201 (-1.8A)RBF A 201 (-3.7A) | 0.88A | 3p5nB-5kbwA:24.2 | 3p5nB-5kbwA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P5N_B_RBFB190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 6 / 12 | LEU A 34ASP A 73GLY A 76LEU A 83ASN A 149LYS A 152 | RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-4.5A)RBF A 201 (-1.8A)RBF A 201 (-3.7A) | 1.39A | 3p5nB-5kbwA:24.2 | 3p5nB-5kbwA:33.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QPS_A_CHDA211_0 (CMER) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 5 / 10 | LEU A 83ALA A 117PHE A 118GLY A 121PHE A 148 | RBF A 201 (-4.5A)NoneNoneNoneRBF A 201 (-4.9A) | 1.39A | 3qpsA-5kbwA:3.2 | 3qpsA-5kbwA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3S_B_9PLB1_1 (CYTOCHROME P450 2A13) |
5w4z | RIBOFLAVIN LYASE (Herbiconiux) | 4 / 6 | PHE A 14ASN A 16ALA A 63THR A 143 | RBF A 502 (-3.6A)RBF A 502 (-3.8A)RBF A 502 ( 3.8A)None | 1.05A | 3t3sB-5w4zA:undetectable | 3t3sB-5w4zA:11.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3S_E_9PLE1_1 (CYTOCHROME P450 2A13) |
5w4z | RIBOFLAVIN LYASE (Herbiconiux) | 4 / 8 | PHE A 14ASN A 16ALA A 63THR A 143 | RBF A 502 (-3.6A)RBF A 502 (-3.8A)RBF A 502 ( 3.8A)None | 1.09A | 3t3sE-5w4zA:undetectable | 3t3sE-5w4zA:11.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQ6_B_ADNB401_2 (ADENOSINE KINASE,PUTATIVE) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 4 / 5 | LEU A 20GLY A 116PHE A 18ASN A 97 | NoneRBF A 402 ( 3.8A)NoneRBF A 402 (-4.0A) | 1.25A | 3uq6B-4r3aA:undetectable | 3uq6B-4r3aA:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZS3_A_ACTA1226_0 (THAUMATIN-LIKEPROTEIN) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 5 | GLU A 40ASP A 156ASN A 149PHE A 148 | NoneNoneRBF A 201 (-1.8A)RBF A 201 (-4.9A) | 1.25A | 3zs3A-5kbwA:0.0 | 3zs3A-5kbwA:18.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZTV_A_ADNA1600_1 (NAD NUCLEOTIDASE) |
4d1y | PUTATIVE PROTEASE I (Bacteroidesthetaiotaomicron) | 5 / 9 | ASN A 14GLY A 15GLY A 17ASN A 161SER A 47 | NoneNoneNoneRBF A1176 (-4.2A)None | 1.14A | 3ztvA-4d1yA:undetectable | 3ztvA-4d1yA:17.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEV_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 7 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.20A | 4fevD-5kbwA:undetectable | 4fevD-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEV_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 7 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.21A | 4fevF-5kbwA:undetectable | 4fevF-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 8 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.21A | 4fewD-5kbwA:undetectable | 4fewD-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_F_KANF301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 8 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.22A | 4fewF-5kbwA:undetectable | 4fewF-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_B_KANB301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 8 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.15A | 4gkhB-5kbwA:undetectable | 4gkhB-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKH_G_KANG301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 7 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.20A | 4gkhG-5kbwA:undetectable | 4gkhG-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_A_KANA301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 8 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.19A | 4gkiA-5kbwA:undetectable | 4gkiA-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_C_KANC301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 4 / 8 | ASP A 63ASP A 156ASN A 80GLU A 24 | NoneNoneNoneRBF A 201 (-4.1A) | 1.11A | 4gkiC-5kbwA:undetectable | 4gkiC-5kbwA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HDL_A_DXCA75_0 (PPCA) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 4 / 8 | ILE A 113LYS A 167ILE A 173PHE A 175 | NoneRBF A 190 (-3.2A)NoneNone | 0.98A | 4hdlA-3p5nA:undetectable | 4hdlA-3p5nA:15.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYT_A_OBNA1104_2 (SODIUM/POTASSIUM-TRANSPORTING ATPASESUBUNIT ALPHA-1) |
4iil | MEMBRANE LIPOPROTEINTPN38(B) (Treponemapallidum) | 4 / 5 | PRO A 83ASP A 105ILE A 164VAL A 286 | RBF A 401 ( 3.7A)RBF A 401 (-3.2A)RBF A 401 ( 4.7A)None | 1.43A | 4hytA-4iilA:2.1 | 4hytA-4iilA:16.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IV0_A_SAMA302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iil | MEMBRANE LIPOPROTEINTPN38(B) (Treponemapallidum) | 5 / 12 | VAL A 221GLY A 154GLY A 187ILE A 152ILE A 213 | NoneNoneNoneNoneRBF A 401 (-3.7A) | 0.98A | 4iv0A-4iilA:undetectable | 4iv0A-4iilA:24.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KUK_A_RBFA201_1 (BLUE-LIGHTPHOTORECEPTOR) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 8 / 12 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 201 (-2.6A)RBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 (-3.0A)RBF A 201 (-2.4A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 (-4.0A) | 0.39A | 4kukA-4r38A:18.4 | 4kukA-4r38A:36.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KUK_A_RBFA201_1 (BLUE-LIGHTPHOTORECEPTOR) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 8 / 12 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 402 (-2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-4.3A) | 0.34A | 4kukA-4r3aA:14.6 | 4kukA-4r3aA:16.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KUK_A_RBFA201_2 (BLUE-LIGHTPHOTORECEPTOR) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 9 | LEU A 58VAL A 68ILE A 85PHE A 114GLY A 116 | RBF A 201 (-3.9A)RBF A 201 (-3.3A)RBF A 201 ( 4.2A)RBF A 201 (-4.4A)RBF A 201 ( 3.3A) | 0.58A | 4kukA-4r38A:18.4 | 4kukA-4r38A:36.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KUK_A_RBFA201_2 (BLUE-LIGHTPHOTORECEPTOR) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 9 | LEU A 58VAL A 68ILE A 85PHE A 114GLY A 116 | RBF A 402 (-4.2A)RBF A 402 (-3.5A)RBF A 402 (-4.0A)RBF A 402 ( 4.3A)RBF A 402 ( 3.8A) | 0.42A | 4kukA-4r3aA:14.6 | 4kukA-4r3aA:16.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KUO_A_RBFA500_1 (BLUE-LIGHTPHOTORECEPTOR) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 8 / 12 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 201 (-2.6A)RBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 (-3.0A)RBF A 201 (-2.4A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 (-4.0A) | 0.35A | 4kuoA-4r38A:18.6 | 4kuoA-4r38A:36.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KUO_A_RBFA500_1 (BLUE-LIGHTPHOTORECEPTOR) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 8 / 12 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 402 (-2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-4.3A) | 0.35A | 4kuoA-4r3aA:14.7 | 4kuoA-4r3aA:16.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWZ_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iil | MEMBRANE LIPOPROTEINTPN38(B) (Treponemapallidum) | 5 / 12 | VAL A 221GLY A 154GLY A 187ILE A 152ILE A 213 | NoneNoneNoneNoneRBF A 401 (-3.7A) | 0.99A | 4mwzB-4iilA:undetectable | 4mwzB-4iilA:22.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NC3_A_ERMA1202_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | SER A 46ALA A 90PHE A 39LEU A 99VAL A 35 | NoneNoneNoneRBF A 201 (-4.2A)None | 1.32A | 4nc3A-4r38A:undetectable | 4nc3A-4r38A:17.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_A_RBFA201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 12 / 12 | ALA A 23CYH A 55ARG A 56GLN A 59ALA A 72ILE A 75ASN A 87ASN A 97LEU A 99MET A 101GLY A 116GLN A 118 | RBF A 402 ( 2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 ( 3.1A)RBF A 402 (-4.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-3.2A)RBF A 402 ( 3.8A)RBF A 402 (-4.3A) | 0.31A | 4r38A-4r3aA:4.2 | 4r38A-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_A_RBFA201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 74GLN A 118ALA A 23ASN A 97ASN A 87 | NoneRBF A 402 (-4.3A)RBF A 402 ( 2.9A)RBF A 402 (-4.0A)RBF A 402 (-2.3A) | 1.20A | 4r38A-4r3aA:4.2 | 4r38A-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_A_RBFA201_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 8 / 8 | THR A 21ILE A 25ASN A 54LEU A 58VAL A 68LEU A 71ILE A 85PHE A 114 | RBF A 402 (-3.4A)NoneRBF A 402 (-2.9A)RBF A 402 (-4.2A)RBF A 402 (-3.5A)RBF A 402 (-3.6A)RBF A 402 (-4.0A)RBF A 402 ( 4.3A) | 0.32A | 4r38A-4r3aA:4.2 | 4r38A-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 12 / 12 | ALA A 23ASN A 54CYH A 55ARG A 56GLN A 59ALA A 72ILE A 75ASN A 87ASN A 97LEU A 99GLY A 116GLN A 118 | RBF A 402 ( 2.9A)RBF A 402 (-2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 ( 3.1A)RBF A 402 (-4.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 ( 3.8A)RBF A 402 (-4.3A) | 0.31A | 4r38B-4r3aA:16.8 | 4r38B-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 23ASN A 54CYH A 55ILE A 75ASN A 87 | RBF A 402 ( 2.9A)RBF A 402 (-2.9A)RBF A 402 (-3.4A)RBF A 402 (-4.3A)RBF A 402 (-2.3A) | 1.06A | 4r38B-4r3aA:16.8 | 4r38B-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 23CYH A 55ALA A 72ILE A 75ASN A 97 | RBF A 402 ( 2.9A)RBF A 402 (-3.4A)RBF A 402 ( 3.1A)RBF A 402 (-4.3A)RBF A 402 (-4.0A) | 1.12A | 4r38B-4r3aA:16.8 | 4r38B-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 74GLN A 118ALA A 23ASN A 97ASN A 87 | NoneRBF A 402 (-4.3A)RBF A 402 ( 2.9A)RBF A 402 (-4.0A)RBF A 402 (-2.3A) | 1.22A | 4r38B-4r3aA:16.8 | 4r38B-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_C_RBFC201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 23CYH A 55ALA A 72ILE A 75ASN A 87 | RBF A 402 ( 2.9A)RBF A 402 (-3.4A)RBF A 402 ( 3.1A)RBF A 402 (-4.3A)RBF A 402 (-2.3A) | 1.01A | 4r38C-4r3aA:16.9 | 4r38C-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_C_RBFC201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 12 / 12 | ALA A 23CYH A 55ARG A 56GLN A 59ALA A 72ILE A 75ASN A 87ASN A 97LEU A 99MET A 101GLY A 116GLN A 118 | RBF A 402 ( 2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 ( 3.1A)RBF A 402 (-4.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-3.2A)RBF A 402 ( 3.8A)RBF A 402 (-4.3A) | 0.33A | 4r38C-4r3aA:16.9 | 4r38C-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_C_RBFC201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 74GLN A 118ALA A 23ASN A 97ASN A 87 | NoneRBF A 402 (-4.3A)RBF A 402 ( 2.9A)RBF A 402 (-4.0A)RBF A 402 (-2.3A) | 1.15A | 4r38C-4r3aA:16.9 | 4r38C-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_C_RBFC201_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 9 / 9 | THR A 21ILE A 25GLU A 30ASN A 54LEU A 58VAL A 68LEU A 71ILE A 85PHE A 114 | RBF A 402 (-3.4A)NoneNoneRBF A 402 (-2.9A)RBF A 402 (-4.2A)RBF A 402 (-3.5A)RBF A 402 (-3.6A)RBF A 402 (-4.0A)RBF A 402 ( 4.3A) | 0.48A | 4r38C-4r3aA:16.9 | 4r38C-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_D_RBFD201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 12 / 12 | ALA A 23CYH A 55ARG A 56GLN A 59ALA A 72ILE A 75ASN A 87ASN A 97LEU A 99MET A 101GLY A 116GLN A 118 | RBF A 402 ( 2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 ( 3.1A)RBF A 402 (-4.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-3.2A)RBF A 402 ( 3.8A)RBF A 402 (-4.3A) | 0.34A | 4r38D-4r3aA:4.0 | 4r38D-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R38_D_RBFD201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | ALA A 74GLN A 118ALA A 23ASN A 97ASN A 87 | NoneRBF A 402 (-4.3A)RBF A 402 ( 2.9A)RBF A 402 (-4.0A)RBF A 402 (-2.3A) | 1.18A | 4r38D-4r3aA:4.0 | 4r38D-4r3aA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_A_RBFA402_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 6 / 12 | ALA A 23CYH A 55ALA A 72ILE A 75ILE A 85ASN A 87 | RBF A 201 ( 3.4A)RBF A 201 (-3.3A)RBF A 201 ( 3.3A)RBF A 201 (-4.2A)RBF A 201 ( 4.2A)RBF A 201 (-2.4A) | 1.35A | 4r3aA-4r38A:17.0 | 4r3aA-4r38A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_A_RBFA402_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 12 / 12 | ALA A 23CYH A 55ARG A 56GLN A 59ALA A 72ILE A 75ILE A 85ASN A 87ASN A 97LEU A 99MET A 101GLN A 118 | RBF A 201 ( 3.4A)RBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 (-3.0A)RBF A 201 ( 3.3A)RBF A 201 (-4.2A)RBF A 201 ( 4.2A)RBF A 201 (-2.4A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 (-3.2A)RBF A 201 (-4.0A) | 0.34A | 4r3aA-4r38A:17.0 | 4r3aA-4r38A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_B_RBFB402_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 10 / 10 | THR A 21ILE A 25GLU A 30ASN A 54LEU A 58GLN A 59VAL A 68LEU A 71MET A 101PHE A 114 | RBF A 201 (-3.1A)NoneNoneRBF A 201 (-2.6A)RBF A 201 (-3.9A)RBF A 201 (-3.0A)RBF A 201 (-3.3A)RBF A 201 ( 3.6A)RBF A 201 (-3.2A)RBF A 201 (-4.4A) | 0.59A | 4r3aB-4r38A:16.8 | 4r3aB-4r38A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_B_RBFB402_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 10 | THR A 21ILE A 75LEU A 58MET A 101PHE A 114 | RBF A 201 (-3.1A)RBF A 201 (-4.2A)RBF A 201 (-3.9A)RBF A 201 (-3.2A)RBF A 201 (-4.4A) | 1.42A | 4r3aB-4r38A:16.8 | 4r3aB-4r38A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_B_RBFB402_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 7 / 12 | ALA A 23LEU A 32CYH A 55ALA A 72ILE A 75ILE A 85ASN A 87 | RBF A 201 ( 3.4A)NoneRBF A 201 (-3.3A)RBF A 201 ( 3.3A)RBF A 201 (-4.2A)RBF A 201 ( 4.2A)RBF A 201 (-2.4A) | 1.33A | 4r3aB-4r38A:16.8 | 4r3aB-4r38A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_B_RBFB402_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 12 / 12 | ALA A 23LEU A 32CYH A 55ARG A 56ALA A 72ILE A 75ILE A 85ASN A 87ASN A 97LEU A 99GLY A 116GLN A 118 | RBF A 201 ( 3.4A)NoneRBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 ( 3.3A)RBF A 201 (-4.2A)RBF A 201 ( 4.2A)RBF A 201 (-2.4A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 ( 3.3A)RBF A 201 (-4.0A) | 0.48A | 4r3aB-4r38A:16.8 | 4r3aB-4r38A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R3A_B_RBFB402_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 6 / 12 | ALA A 23LEU A 32CYH A 55ARG A 56ILE A 75ASN A 97 | RBF A 201 ( 3.4A)NoneRBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 (-3.7A) | 1.05A | 4r3aB-4r38A:16.8 | 4r3aB-4r38A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AJQ_A_DB8A800_2 (SERINE/THREONINE-PROTEIN KINASE 10) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 4 / 4 | VAL A 134ILE A 129ASN A 164VAL A 157 | NoneNoneRBF A 190 (-3.3A)None | 1.03A | 5ajqA-3p5nA:undetectable | 5ajqA-3p5nA:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 5 / 12 | PHE A 33LEU A 34ALA A 31TYR A 138ILE A 145 | RBF A 201 (-4.4A)RBF A 201 (-4.9A)NoneNoneRBF A 201 ( 4.6A) | 1.08A | 5h8tA-5kbwA:undetectable | 5h8tA-5kbwA:20.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3C_B_AC2B301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
4e0f | RIBOFLAVIN SYNTHASESUBUNIT ALPHA (Brucellaabortus) | 5 / 10 | ALA A 67VAL A 65GLU A 66ASP A 13ILE A 26 | RBF A 301 (-4.1A)NoneNoneNoneNone | 1.04A | 5i3cB-4e0fA:undetectable | 5i3cB-4e0fA:23.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KBW_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 7 / 12 | LEU A 42ASP A 81GLY A 84ASN A 88ASN A 131ASN A 164LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.3A)RBF A 190 (-3.2A) | 0.82A | 5kbwA-3p5nA:24.2 | 5kbwA-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KBW_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 6 / 12 | LEU A 42ASP A 81GLY A 84LEU A 127ASN A 164LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 (-4.1A)RBF A 190 (-3.3A)RBF A 190 (-3.2A) | 1.38A | 5kbwA-3p5nA:24.2 | 5kbwA-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KBW_B_RBFB201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 5 / 12 | ASP A 81GLY A 84ASN A 88ASN A 131ASN A 164 | RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.3A) | 0.65A | 5kbwB-3p5nA:24.1 | 5kbwB-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KBW_B_RBFB201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 5 / 12 | ASP A 81GLY A 84ASN A 88ASN A 131LYS A 167 | RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.2A) | 0.73A | 5kbwB-3p5nA:24.1 | 5kbwB-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KBW_B_RBFB201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 5 / 12 | LEU A 42GLY A 84ASN A 88ASN A 131ASN A 164 | RBF A 190 (-4.6A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.3A) | 0.49A | 5kbwB-3p5nA:24.1 | 5kbwB-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KBW_B_RBFB201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 5 / 12 | LEU A 42GLY A 84ASN A 88ASN A 131LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.2A) | 0.56A | 5kbwB-3p5nA:24.1 | 5kbwB-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC0_A_RBFA303_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 7 / 12 | LEU A 42ASP A 81GLY A 84ASN A 88ASN A 131ASN A 164LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.3A)RBF A 190 (-3.2A) | 1.00A | 5kc0A-3p5nA:24.0 | 5kc0A-3p5nA:31.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC0_A_RBFA303_1 (RIBOFLAVINTRANSPORTER RIBU) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 12 / 12 | GLU A 24LEU A 34LYS A 70ASP A 73GLY A 76MET A 79ASN A 80ALA A 119ASN A 123ASN A 149LYS A 152PHE A 153 | RBF A 201 (-4.1A)RBF A 201 (-4.9A)RBF A 201 ( 4.0A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-3.5A)NoneRBF A 201 (-3.3A)RBF A 201 (-2.1A)RBF A 201 (-1.8A)RBF A 201 (-3.7A)RBF A 201 ( 4.7A) | 0.60A | 5kc0A-5kbwA:29.3 | 5kc0A-5kbwA:94.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 7 / 12 | LEU A 42ASP A 81GLY A 84ASN A 88ASN A 131ASN A 164LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-3.3A)RBF A 190 (-3.2A) | 1.04A | 5kc4A-3p5nA:23.6 | 5kc4A-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 6 / 12 | GLU A 24LEU A 34ASP A 73GLY A 76MET A 79ASN A 123 | RBF A 201 (-4.1A)RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-3.5A)RBF A 201 (-2.1A) | 0.89A | 5kc4A-5kbwA:28.8 | 5kc4A-5kbwA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 11 / 12 | LEU A 34LYS A 70ASP A 73GLY A 76MET A 79ASN A 80ALA A 119ASN A 123ASN A 149LYS A 152PHE A 153 | RBF A 201 (-4.9A)RBF A 201 ( 4.0A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-3.5A)NoneRBF A 201 (-3.3A)RBF A 201 (-2.1A)RBF A 201 (-1.8A)RBF A 201 (-3.7A)RBF A 201 ( 4.7A) | 0.62A | 5kc4A-5kbwA:28.8 | 5kc4A-5kbwA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_E_RBFE201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 8 / 12 | LEU A 42ASP A 81GLY A 84ASN A 88ASN A 131PHE A 163ASN A 164LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 ( 4.9A)RBF A 190 (-3.6A)RBF A 190 (-4.5A)RBF A 190 (-3.3A)RBF A 190 (-3.2A) | 0.95A | 5kc4E-3p5nA:23.4 | 5kc4E-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_E_RBFE201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 7 / 12 | LEU A 42ASP A 81GLY A 84LEU A 127PHE A 163ASN A 164LYS A 167 | RBF A 190 (-4.6A)RBF A 190 (-3.0A)RBF A 190 (-3.1A)RBF A 190 (-4.1A)RBF A 190 (-4.5A)RBF A 190 (-3.3A)RBF A 190 (-3.2A) | 1.29A | 5kc4E-3p5nA:23.4 | 5kc4E-3p5nA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_E_RBFE201_1 (RIBOFLAVINTRANSPORTER RIBU) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 11 / 12 | GLU A 24LEU A 34ASP A 73GLY A 76MET A 79ASN A 80LEU A 83ALA A 119ASN A 123PHE A 148ASN A 149 | RBF A 201 (-4.1A)RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-3.5A)NoneRBF A 201 (-4.5A)RBF A 201 (-3.3A)RBF A 201 (-2.1A)RBF A 201 (-4.9A)RBF A 201 (-1.8A) | 0.71A | 5kc4E-5kbwA:28.4 | 5kc4E-5kbwA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_E_RBFE201_1 (RIBOFLAVINTRANSPORTER RIBU) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 11 / 12 | GLU A 24LEU A 34ASP A 73GLY A 76MET A 79ASN A 80LEU A 83ALA A 119PHE A 148ASN A 149LYS A 152 | RBF A 201 (-4.1A)RBF A 201 (-4.9A)RBF A 201 (-4.0A)RBF A 201 (-2.9A)RBF A 201 (-3.5A)NoneRBF A 201 (-4.5A)RBF A 201 (-3.3A)RBF A 201 (-4.9A)RBF A 201 (-1.8A)RBF A 201 (-3.7A) | 0.72A | 5kc4E-5kbwA:28.4 | 5kc4E-5kbwA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KC4_E_RBFE201_2 (RIBOFLAVINTRANSPORTER RIBU) |
5kbw | RIBOFLAVINTRANSPORTER RIBU (Thermotogamaritima) | 3 / 3 | LYS A 35ASP A 37ILE A 145 | RBF A 201 (-3.3A)NoneRBF A 201 ( 4.6A) | 0.54A | 5kc4E-5kbwA:28.4 | 5kc4E-5kbwA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KOC_B_SAMB401_0 (PAVINEN-METHYLTRANSFERASE) |
4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) | 5 / 12 | GLY A 116THR A 21ASN A 36GLN A 118LEU A 148 | RBF A 402 ( 3.8A)RBF A 402 (-3.4A)NoneRBF A 402 (-4.3A)None | 1.07A | 5kocB-4r3aA:undetectable | 5kocB-4r3aA:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C2M_C_SUEC1203_0 (NS3 PROTEASE) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 5 / 12 | VAL A 49ASP A 48GLY A 84ALA A 91SER A 128 | NoneNoneRBF A 190 (-3.1A)RBF A 190 (-3.4A)None | 1.01A | 6c2mC-3p5nA:undetectable | 6c2mC-3p5nA:17.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C2M_C_SUEC1203_0 (NS3 PROTEASE) |
3p5n | RIBOFLAVIN UPTAKEPROTEIN (Staphylococcusaureus) | 5 / 12 | VAL A 49ASP A 48GLY A 84ALA A 91VAL A 126 | NoneNoneRBF A 190 (-3.1A)RBF A 190 (-3.4A)None | 0.97A | 6c2mC-3p5nA:undetectable | 6c2mC-3p5nA:17.49 |